Concourse Financial Group Securities, Inc. Dia Medica Therapeutics Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$2.8 - $4.49 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$2.16 - $3.66 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$2.58 - $3.23 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$2.05 - $2.99 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$2.56 - $4.4 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$2.56 - $4.4 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$1.53 - $4.4 $0 - $0
Q1 2023 May 15, 2023	BUY	$1.32 - $1.89 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$1.13 - $1.62 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.2 - $2.07 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$1.86 - $2.62 $0 - $0
Q1 2022 May 09, 2022	BUY	$2.29 - $3.88 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$3.43 - $4.65 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$3.1 - $4.32 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$4.45 - $9.91 $0 - $0
Q1 2021 May 13, 2021	BUY	$7.76 - $10.43 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$4.13 - $10.14 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$3.91 - $7.15 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$2.6 - $7.32 $0 - $0
Q1 2020 May 13, 2020	BUY	$2.25 - $5.64 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$1.8 - $5.04 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$2.07 - $4.88 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$2.7 - $4.96 $0 - $0
Q1 2019 May 15, 2019	BUY	$3.1 - $4.54 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$2.65 - $9.2 $0 - $0

Others Institutions Holding DMAC

# of Institutions

Shares Held

3.87M

Call Options Held

1.3K

Put Options Held

Vanguard Group Inc Valley Forge, PA

1.02M
Shares

$4.48 Million
0.0% of portfolio
First Manhattan CO New York, NY

839K
Shares

$3.69 Million
0.01% of portfolio
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX

483K
Shares

$2.12 Million
3.48% of portfolio
Bleichroeder LP New York, NY

382K
Shares

$1.68 Million
0.41% of portfolio
Geode Capital Management, LLC Boston, MA

237K
Shares

$1.04 Million
0.0% of portfolio

View Full List

About DiaMedica Therapeutics Inc.

Ticker DMAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,443,100
Market Cap $116M
Description
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...

More about DMAC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account